Results 231 to 240 of about 10,802,441 (400)
Peptide-encoding gene transfer to modulate intracellular protein-protein interactions
Peptide drug discovery has great potential, but the cell membrane is a major obstacle when the target is an intracellular protein-protein interaction (PPI). It is difficult to target PPIs with small molecules; indeed, there are no intervention tools that
Toshihiko Taya+4 more
doaj
Environmental DNA adsorption to chitin can promote horizontal gene transfer by natural transformation. [PDF]
Holt JD+4 more
europepmc +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
Loss of Pathogenicity and Evidence of Horizontal Gene Transfer in Colletotrichum gloeosporioides From a Medicinal Plant. [PDF]
Yue X+17 more
europepmc +1 more source
Recognition of EBV plasma membrane protein expressed on murine cells after gene transfer. [PDF]
Carol Shoshkes Reiss+4 more
openalex +1 more source
The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems [PDF]
Koch, Christian+4 more
core
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Ancient Host-Virus Gene Transfer Hints at a Diverse Pre-LECA Virosphere. [PDF]
Karki S, Barth ZK, Aylward FO.
europepmc +1 more source
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi+2 more
wiley +1 more source